Skip to main content
. 2000 Feb;38(2):768–772. doi: 10.1128/jcm.38.2.768-772.2000

FIG. 1.

FIG. 1

Distribution of CMV viral burdens in lung transplant recipients. Column A, levels of CMV DNA in the plasma of patients who remained asymptomatic; column B, levels 12 to 4 weeks prior to development of symptoms; column C, levels at clinical diagnosis.